Medicine
Bisoprolol 5 mg tablet
Bisoprolol 5 mg tablet is a generic prescription medicine for oral use, made by 22 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from moisture.
Key facts
- Active ingredient (INN)
- Bisoprolol
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 500 tablets and 61 more
- Manufacturers
- Alembic PharmaceuticalsIndiaMicro LabsIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaNatco PharmaIndiaSun Pharmaceutical IndustriesIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAdvagen PharmaBryant Ranch Prepack22 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AB07 Bisoprolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 November 2000
- Identifiers
- RxCUI 854905, 854901, 865155DailyMed set ID f6ce8f14-43fc-4c5e-8378-62ca7121e918, 78056d0b-2265-4da3-a4fe-b96d98289848, df37d337-9978-0c31-e053-2a95a90a3258 +23NDC 71335-2178, 72162-2177, 51407-645 +23Application ANDA215563, ANDA075474, ANDA204891 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 22 labelers. The register lists 64 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle, plastic | 46708-603-30 | Alembic PharmaceuticalsIndia | 11 September 2019 |
| 100 tablet, film coated in 1 bottle, plastic | 46708-603-31 | Alembic PharmaceuticalsIndia | 25 March 2021 |
| 500 tablet, film coated in 1 bottle, plastic | 46708-603-71 | Alembic PharmaceuticalsIndia | 11 September 2019 |
| 30 tablet, film coated in 1 bottle, plastic | 62332-603-30 | Alembic PharmaceuticalsIndia | 11 September 2019 |
| 100 tablet, film coated in 1 bottle, plastic | 62332-603-31 | Alembic PharmaceuticalsIndia | 25 March 2021 |
| 500 tablet, film coated in 1 bottle, plastic | 62332-603-71 | Alembic PharmaceuticalsIndia | 11 September 2019 |
| 100 tablet, film coated in 1 bottle | 65862-086-01 | Aurobindo PharmaIndia | 27 December 2006 |
| 30 tablet, film coated in 1 bottle | 65862-086-30 | Aurobindo PharmaIndia | 27 December 2006 |
| 100 tablet, film coated in 1 bottle | 42571-470-01 | Micro LabsIndia | 1 June 2026 |
| 500 tablet, film coated in 1 bottle | 42571-470-05 | Micro LabsIndia | 1 June 2026 |
| 30 tablet, film coated in 1 bottle | 42571-470-30 | Micro LabsIndia | 1 June 2026 |
| 100 tablet in 1 bottle, plastic | 69339-236-01 | Natco PharmaIndia | 25 November 2024 |
| 30 tablet in 1 bottle, plastic | 69339-236-03 | Natco PharmaIndia | 25 November 2024 |
| 30 tablet, film coated in 1 bottle, unit-dose | 70095-020-01 | Sun Pharmaceutical IndustriesIndia | 10 March 2024 |
| 100 tablet, film coated in 1 bottle | 70095-020-02 | Sun Pharmaceutical IndustriesIndia | 10 March 2024 |
| 100 tablet in 1 bottle, plastic | 29300-126-01 | Unichem LaboratoriesIndia | 21 September 2009 |
| 500 tablet in 1 bottle, plastic | 29300-126-05 | Unichem LaboratoriesIndia | 19 August 2016 |
| 30 tablet in 1 bottle, plastic | 29300-126-13 | Unichem LaboratoriesIndia | 21 September 2009 |
| 100 tablet, film coated in 1 bottle | 72578-111-01 | Viona PharmaceuticalsIndia | 15 September 2022 |
| 30 tablet, film coated in 1 bottle | 72578-111-06 | Viona PharmaceuticalsIndia | 15 September 2022 |
| 100 tablet, film coated in 1 bottle | 70771-1726-1 | Zydus LifesciencesIndia | 15 September 2022 |
| 30 tablet, film coated in 1 bottle | 70771-1726-3 | Zydus LifesciencesIndia | 15 September 2022 |
| 1000 tablet, film coated in 1 bottle | 72888-092-00 | Advagen Pharma | 1 July 2022 |
| 100 tablet, film coated in 1 bottle | 72888-092-01 | Advagen Pharma | 1 July 2022 |
| 500 tablet, film coated in 1 bottle | 72888-092-05 | Advagen Pharma | 1 July 2022 |
| 30 tablet, film coated in 1 bottle | 72888-092-30 | Advagen Pharma | 1 July 2022 |
| 30 tablet in 1 bottle | 82638-107-01 | Harman Finochem | 30 July 2024 |
| 100 tablet in 1 bottle | 82638-107-02 | Harman Finochem | 30 July 2024 |
| 30 tablet in 1 bottle | 70954-455-10 | Novitium Pharma | 29 October 2021 |
| 100 tablet in 1 bottle | 70954-455-20 | Novitium Pharma | 29 October 2021 |
| 100 tablet, film coated in 1 bottle | 64980-709-01 | Rising Pharma Holdings | 11 July 2025 |
| 30 tablet, film coated in 1 bottle | 64980-709-03 | Rising Pharma Holdings | 11 July 2025 |
| 30 tablet in 1 bottle | 43547-616-03 | Solco Healthcare | 5 July 2022 |
| 100 tablet in 1 bottle | 43547-616-10 | Solco Healthcare | 5 July 2022 |
| 500 tablet in 1 bottle | 43547-616-50 | Solco Healthcare | 5 July 2022 |
| 100 tablet, film coated in 1 bottle | 52817-270-10 | TruPharma | 20 June 2019 |
| 30 tablet, film coated in 1 bottle | 52817-270-30 | TruPharma | 20 June 2019 |
| 30 tablet in 1 bottle | 63629-5173-1 | Bryant Ranch Prepack | 16 December 2013 |
| 100 tablet in 1 bottle | 63629-5173-2 | Bryant Ranch Prepack | 16 December 2013 |
| 90 tablet in 1 bottle | 63629-5173-3 | Bryant Ranch Prepack | 16 December 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 July 1992 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bisoprolol
Clinical summary
Bisoprolol is a beta-adrenergic blocker indicated in the management of hypertension. It is available as tablets for oral use. MedsAcross supplies Bisoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BisoprololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BISOPROLOL FUMARATE prescribing information (Sun Pharmaceutical Industries) · U.S. National Library of Medicine, DailyMed
Need Bisoprolol 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.